| Literature DB >> 18206603 |
Abstract
Pompe's disease (glycogen storage disease type II) is a lysosomal storage disorder resulting from a deficiency in alpha 1, 4 glucosidase. Prognosis is poor because of heart involvement. Treatment in adult form relies on supportive therapy. Enzyme replacement therapy with recombinant human alpha glucosidase remains a hope for patients.Entities:
Mesh：
Year: 2007 PMID： 18206603 DOI： 10.1016/j.ejim.2007.09.018
Source DB: PubMed Journal: Eur J Intern Med ISSN： 0953-6205 Impact factor: 4.487